Retrospective Analysis of Master Protocols in Tumor‐Agnostic Drug Development: Evaluation of Application to Single‐Agent Therapies With ORR as the Endpoint for Approval of Oncology Drugs

ABSTRACT The first global approval of a microsatellite instability‐high solid tumors was a landmark in oncology, paving the way for targeted therapies approved globally. However, guidance remains limited regarding the biological and methodological conditions under which such designs, statistical bor...

Full description

Saved in:
Bibliographic Details
Main Authors: Keiko Yamamoto, Kentaro Takeda, Hideki Maeda
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Clinical and Translational Science
Subjects:
Online Access:https://doi.org/10.1111/cts.70313
Tags: Add Tag
No Tags, Be the first to tag this record!